IL166513A0 - Lamellarin derivatives and pharmaceutical compositions containing the same - Google Patents
Lamellarin derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL166513A0 IL166513A0 IL16651305A IL16651305A IL166513A0 IL 166513 A0 IL166513 A0 IL 166513A0 IL 16651305 A IL16651305 A IL 16651305A IL 16651305 A IL16651305 A IL 16651305A IL 166513 A0 IL166513 A0 IL 166513A0
- Authority
- IL
- Israel
- Prior art keywords
- same
- pharmaceutical compositions
- compositions containing
- lamellarin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0218816.7A GB0218816D0 (en) | 2002-08-13 | 2002-08-13 | Antitumoral analogs of lamellarins |
PCT/GB2003/003541 WO2004014917A2 (en) | 2002-08-13 | 2003-08-13 | Antitumoral analogs of lamellarins |
Publications (1)
Publication Number | Publication Date |
---|---|
IL166513A0 true IL166513A0 (en) | 2006-01-15 |
Family
ID=9942234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16651305A IL166513A0 (en) | 2002-08-13 | 2005-01-26 | Lamellarin derivatives and pharmaceutical compositions containing the same |
Country Status (17)
Country | Link |
---|---|
US (1) | US7396837B2 (ko) |
EP (2) | EP2138496A1 (ko) |
JP (1) | JP2005536529A (ko) |
KR (1) | KR20050053613A (ko) |
CN (2) | CN1688585A (ko) |
AT (1) | ATE475663T1 (ko) |
AU (1) | AU2003252997B2 (ko) |
CA (1) | CA2493725A1 (ko) |
DE (1) | DE60333578D1 (ko) |
GB (1) | GB0218816D0 (ko) |
HK (1) | HK1078580A1 (ko) |
IL (1) | IL166513A0 (ko) |
MX (1) | MXPA05001731A (ko) |
NO (1) | NO20051282L (ko) |
NZ (1) | NZ537935A (ko) |
RU (1) | RU2328500C2 (ko) |
WO (1) | WO2004014917A2 (ko) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071587B2 (en) | 2009-05-27 | 2011-12-06 | N. V. Organon | (Dihydro)imidazoiso[5,1-A]quinolines |
US8431564B2 (en) | 2009-07-29 | 2013-04-30 | Merck Sharp & Dohme B.V. | Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
TW201116531A (en) | 2009-07-29 | 2011-05-16 | Organon Nv | Ring-annulated dihydropyrrolo[2,1-a]isoquinolines |
WO2011035417A1 (en) * | 2009-09-25 | 2011-03-31 | Aegera Therapeutics Inc. | Hsp-90 binding compounds, compositions thereof, and their use fn the treatment of autoimmune and inflammatory diseases |
JP5888702B2 (ja) * | 2011-01-17 | 2016-03-22 | 国立大学法人 長崎大学 | 抗癌活性化合物 |
WO2012126084A1 (en) * | 2011-03-24 | 2012-09-27 | Pharmascience Inc. | Hsp-90 binding compounds, compositions thereof, and their use iν the treatment and prevention of fungal infections |
KR101721029B1 (ko) * | 2014-10-16 | 2017-03-29 | 연세대학교 산학협력단 | 인돌리지노[3,2-c]퀴놀린 유도체, 이의 약제학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 낭포성 섬유증 예방 또는 치료용 약학조성물 |
TWI674265B (zh) * | 2017-03-27 | 2019-10-11 | 東海大學 | 片螺素及其衍生物之製造方法 |
WO2018181777A1 (ja) * | 2017-03-29 | 2018-10-04 | 国立大学法人 長崎大学 | 第四世代egfrチロシンキナーゼ阻害剤 |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
CN112300232B (zh) * | 2020-11-03 | 2021-11-09 | 浙江大学 | Lamellarin D糖基化衍生物及其制备和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5852033A (en) | 1995-06-29 | 1998-12-22 | Pharma Mar, S.A. | Methods of treatment using lamellarin-class alkaloids |
AUPO656597A0 (en) * | 1997-05-02 | 1997-05-29 | Australian National University, The | Preparation of therapeutic compounds |
AUPP433398A0 (en) * | 1998-06-25 | 1998-07-16 | Australian National University, The | Compounds and processes |
-
2002
- 2002-08-13 GB GBGB0218816.7A patent/GB0218816D0/en not_active Ceased
-
2003
- 2003-08-13 CA CA002493725A patent/CA2493725A1/en not_active Abandoned
- 2003-08-13 KR KR1020057002432A patent/KR20050053613A/ko not_active Application Discontinuation
- 2003-08-13 RU RU2005106863/04A patent/RU2328500C2/ru not_active IP Right Cessation
- 2003-08-13 AU AU2003252997A patent/AU2003252997B2/en not_active Ceased
- 2003-08-13 CN CNA038241609A patent/CN1688585A/zh active Pending
- 2003-08-13 DE DE60333578T patent/DE60333578D1/de not_active Expired - Lifetime
- 2003-08-13 EP EP09171320A patent/EP2138496A1/en not_active Withdrawn
- 2003-08-13 EP EP03784300A patent/EP1551844B1/en not_active Expired - Lifetime
- 2003-08-13 US US10/524,151 patent/US7396837B2/en not_active Expired - Fee Related
- 2003-08-13 AT AT03784300T patent/ATE475663T1/de not_active IP Right Cessation
- 2003-08-13 WO PCT/GB2003/003541 patent/WO2004014917A2/en active Application Filing
- 2003-08-13 NZ NZ537935A patent/NZ537935A/en not_active IP Right Cessation
- 2003-08-13 JP JP2004527072A patent/JP2005536529A/ja active Pending
- 2003-08-13 MX MXPA05001731A patent/MXPA05001731A/es active IP Right Grant
- 2003-08-13 CN CN2010102698414A patent/CN101941977A/zh active Pending
-
2005
- 2005-01-26 IL IL16651305A patent/IL166513A0/xx unknown
- 2005-03-10 NO NO20051282A patent/NO20051282L/no not_active Application Discontinuation
-
2006
- 2006-01-11 HK HK06100423.1A patent/HK1078580A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20050053613A (ko) | 2005-06-08 |
AU2003252997A1 (en) | 2004-02-25 |
CN101941977A (zh) | 2011-01-12 |
GB0218816D0 (en) | 2002-09-18 |
HK1078580A1 (en) | 2006-03-17 |
CN1688585A (zh) | 2005-10-26 |
WO2004014917A2 (en) | 2004-02-19 |
NZ537935A (en) | 2007-02-23 |
RU2328500C2 (ru) | 2008-07-10 |
EP1551844B1 (en) | 2010-07-28 |
AU2003252997B2 (en) | 2009-08-06 |
MXPA05001731A (es) | 2005-08-16 |
ATE475663T1 (de) | 2010-08-15 |
DE60333578D1 (de) | 2010-09-09 |
WO2004014917A3 (en) | 2004-05-13 |
EP2138496A1 (en) | 2009-12-30 |
CA2493725A1 (en) | 2004-02-19 |
US20060173030A1 (en) | 2006-08-03 |
NO20051282L (no) | 2005-05-11 |
JP2005536529A (ja) | 2005-12-02 |
US7396837B2 (en) | 2008-07-08 |
RU2005106863A (ru) | 2005-11-10 |
EP1551844A2 (en) | 2005-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL166513A0 (en) | Lamellarin derivatives and pharmaceutical compositions containing the same | |
DE69831868D1 (en) | Antithrombosemittel | |
AUPR213700A0 (en) | Antiviral agents | |
CA2400268A1 (en) | Pyrrolopyrimidinone derivatives, process of preparation and use | |
CA2510853A1 (en) | Pyrrolopyrimidine derivatives | |
IL133623A0 (en) | Antithrombotic agents | |
WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
CA2373117A1 (en) | 13-methyl-erythromycin derivatives | |
EP2269608A3 (en) | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor | |
WO2006042954A8 (fr) | Dérivés de 2-amido-4-phenylthiazole, leur préparation et leur application en thérapeutique | |
DE602004011966D1 (en) | Heterocyclylverbindungen | |
AU2001286768A1 (en) | Novel macrocycles and uses thereof | |
CA2412047A1 (en) | Shortened synthesis of 3,3-diarylpropylamine derivatives | |
PT992509E (pt) | Novos derivados macrolidos | |
GEP20074127B (en) | Proline derivatives having affinity for the calcium channel alpha-2-delta subunit | |
WO2004014389A8 (en) | 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors | |
DE60114640D1 (en) | Antithrombosemittel | |
MXPA05006889A (es) | Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. | |
WO2001010860A3 (en) | Quinazolinone and azaquinazolinone derivatives | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
EP1404652A4 (en) | NEW ALKALOID DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | |
EP1434762A4 (en) | 4'-METHANSULFONYLBIPHENYL DERIVATIVES AS HIGH-DETECTIVE CYCLOOXYGENASE-2 INHIBITORS | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
TW200510370A (en) | Urea derivatives | |
AU2003218141A1 (en) | Potent, simplified derivatives of immunosuppressive agents |